Abstract
There have been various reports on the association of hepatitis C virus (HCV) infection with B lymphocyte proliferative disorders, such as non-Hodgkin lymphoma (NHL). We experienced a case (Case 1) of anti-HCV antibody (HCV-Ab)-positive NHL in which HCV nonstructural protein 3 (NS3) expression was observed in lymphoma tissue at the time of recurrence and in which the serum HCV RNA level exhibited a transient increase prior to recurrence. We investigated the HCV RNA genome in lymphoma tissue in Case 1, and it could be detected at recurrence. We also investigated HCV NS3 protein expression in lymphoma tissue and changes in serum HCV RNA level during the clinical course in four other cases of HCV-Ab-positive NHL treated in our hospital. We examined lymphoma tissues for HCV NS3 protein expression in four of the five cases, but it was not identified except for in Case 1 at recurrence. In three cases with no recurrence, serum HCV RNA levels showed a tendency to decrease after completion of chemotherapy and became stable thereafter. Further studies are necessary to clarify the association between serum HCV RNA and the onset and exacerbation of NHL.
References
Turner NC, Dusheiko G, Jones A, et al. Hepatitis C and B-cell lymphoma. Ann Oncol. 2003;14:1341–5.
Weng WK, Levy S. Hepatitis C virus (HCV) and lymphomagenesis. Leuk Lymphoma. 2003;44(7):1113–20.
Takeuchi T, Katsume A, Tanaka T, et al. Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology. 1999;116(3):636–42.
Vallisa D, Bertè R, Rocca A, et al. Association between hepatitis C virus and non-Hodgkin’s lymphoma, and effects of viral infection on histologic subtype and clinical course. Am J Med. 1999;106(5):556–60.
Talamini R, Montella M, Crovatto M, et al. Non-Hodgkin’s lymphoma and hepatitis C virus: a case–control study from northern and southern Italy. Int J Cancer. 2004;110(3):380–5.
Engels EA, Chatterjee N, Cerhan JR, et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case–control study. Int J Cancer. 2004;111(1):76–80.
De Sanjose S, Nieters A, Goedert JJ, et al. Role of hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer. 2004;111(1):81–5.
Takeshita M, Sakai H, Okamura S, et al. Prevalence of hepatitis C virus infection in cases of B-cell lymphoma in Japan. Histopathology. 2006;48:189–98.
Pioltelli P, Gargantini L, Cassi E et al. Hepatitis C virus in non-Hodgkin’s lymphoma. A reappraisal after a prospective case–control study of 300 patients. Am J Hematol. 2000;64(2):95–100.
Hausfater P, Cacoub P, Sterkers Y, et al. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol. 2001;67(3):168–71.
Avilès A, Valdez L, Halabe J, et al. No association between lymphoma and hepatitis C virus. Med Oncol. 2003;20(2):165–8.
Mele A, Pulsoni A, Bianco E, et al. Hepatitis C virus and B-cell non-Hodgkin’s lymphomas: an Italian multicenter case–control study. Blood. 2003;102(3):996–9.
Rosa D, Saletti G, De Gregorio E, et al. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA. 2005;102(51):18544–9.
Quinn ER, Chan CH, Hadlock KG, et al. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood. 2001;98(13):3745–9.
Takeshita M, Sakai H, Okamura S, et al. Splenic large B-cell lymphoma in patients with hepatitis C virus infection. Hum Pathol. 2005;36:878–85.
Paydas S, Ergin M, Tanriverdi K, et al. Detection of hepatitis C virus RNA in paraffin-embedded tissues from patients with non-Hodgkin’s lymphoma. Am J Hematol. 2004;76:252–7.
Sebastian J K, Gururaj K, Huifeng-Jenny L, et al. Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin lymphoma. Hematopathology. 2000;113:391–8.
Antonio T, Giovanni B, Francesco C, et al. Detection of HCV RNA in gastric mucosa-associated lymphoid tissue by in situ hybridization : evidence of a new extrahepatic localization of HCV with increased risk of gastric Malt lymphoma. Am J Gastroenterol. 2002;97(7):1802–6.
Emilio I, Emanuele A, Claudio T, et al. Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment. Hematol J. 2004;5:530–3.
Hermine O, Lefrère F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347(2):89–94.
Kelaidi C, Rollot F, Park S, et al. Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Leukemia. 2004;18(10):1711–6.
Vallisa D, Bernuzzi P, Arcaini L, et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin’s lymphoma: a multicenter Italian experience. J Clin Oncol. 2005;23(3):468–73.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Shiratori, S., Tsutsumi, Y., Kawamura, T. et al. HCV non-structural protein 3 and HCV RNA genome in non-Hodgkin lymphoma and transition of the serum HCV RNA level: a retrospective analysis in one institution. Int J Hematol 87, 298–302 (2008). https://doi.org/10.1007/s12185-008-0050-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-008-0050-2